Keyphrases
Clinical Utility
100%
Hepatocellular Carcinoma
100%
Unresectable Hepatocellular Carcinoma
100%
Tremelimumab
100%
Systemic Therapy
50%
Advanced Hepatocellular Carcinoma
50%
Barcelona Clinic Liver Cancer
50%
Liver Transplantation
25%
Immunogenicity
25%
Surgical Resection
25%
Health Care Costs
25%
First-line Therapy
25%
Cancer Causes
25%
Cancer Mortality
25%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
25%
Targeted Immunotherapy
25%
Blocking Antibodies
25%
Targeted Agents
25%
Programmed death-1 Inhibitor
25%
Liver-directed Therapy
25%
Caregiver Burden
25%
Durvalumab
25%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Ticilimumab
100%
Systemic Therapy
25%
Liver Cancer
25%
Malignant Neoplasm
12%
Health Care Cost
12%
Immunotherapy
12%
Liver Transplantation
12%
Surgery
12%
Immunogenicity
12%
Cancer Staging
12%
Blocking Antibody
12%
CTLA-4
12%
Programmed Death 1 Ligand 1
12%
Durvalumab
12%